Schneyer Mark C.

CIK 00018999771 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001899977

Recent Transactions

50 trades

Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-11-18$23.69/sh−10,262→ 53,338 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-11-17+9,913→ 53,687 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-11-17−9,913→ 0 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-11-17−9,913→ 0 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-11-17+9,913→ 63,600 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-09-15$23.65/sh−3,498→ 43,447 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-09-12+6,815→ 46,945 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-08-18$25.18/sh−22,000→ 40,130 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-05-16$25.00/sh−2,000→ 62,130 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-05-02$14.60/sh−3,498→ 62,773 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-05-01−6,815→ 13,630 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-05-01+6,815→ 66,271 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-04-08$14.82/sh−2,708→ 59,456 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-04-05+5,275→ 62,164 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-04-05−5,275→ 5,276 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-03-26$17.05/sh−3,171→ 56,889 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-03-25+6,178→ 60,060 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-03-25−6,178→ 18,536 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (Right to Buy)
2025-03-24+110,761→ 110,761 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-03-24+32,552→ 32,552 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-02-24$19.96/sh−773→ 53,882 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-02-23−1,353→ 0 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-02-23+1,353→ 54,655 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-11-19$16.81/sh−10,259→ 53,302 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-11-17+9,913→ 63,561 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-11-17−9,913→ 9,913 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-11-17+9,913→ 53,648 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-11-17−9,913→ 9,913 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-08-19$15.28/sh−9,733→ 43,735 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-08-16+13,629→ 53,468 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-08-16+5,275→ 39,839 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-06-10$14.79/sh−975→ 34,564 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-06-08−1,893→ 0 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-06-08+1,893→ 35,539 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-05-02$16.94/sh−3,503→ 32,053 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-05-01+6,814→ 35,556 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-05-01−6,814→ 20,445 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-04-08$17.87/sh−2,716→ 28,742 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-04-05+5,275→ 31,458 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-04-05−5,275→ 10,551 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-03-27$17.90/sh−5,434→ 26,183 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Options (Right to Buy)
2024-03-25+80,564→ 80,564 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-03-25+24,714→ 24,714 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-03-25+10,550→ 31,617 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-02-26$24.67/sh−772→ 21,067 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-02-23+1,353→ 21,839 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-02-23−1,353→ 1,353 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-11-20$22.64/sh−5,108→ 20,486 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-11-17−4,956→ 19,826 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-11-17−4,956→ 19,826 total

Companies

ACADIA PHARMACEUTICALS INC
EVP, CHIEF FINANCIAL OFFICER
$ACAD

Recent Filings

Address

C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400

SAN DIEGO, CA, 92130

View on SEC.gov